
In this article, we will explore a fundamental analysis of two prominent pharmaceutical companies, Pfizer Inc. (PFE) and Teva Pharmaceutical Industries Limited (TEVA). This analysis reveals that TEVA stands out as the superior choice for both growth and value investment.
The pharmaceutical industry's strong performance is driven by robust demand. The industry’s growth is boosted by innovations like cell and gene therapy, mRNA vaccine technology, changing supply chains, and evolving product offerings.